**Question:** Deficiency of enzyme a-keto acid decarboxylase leading to a block in the metabolism of branch chain amino acids is observed in -

A. Alanylglutaminase deficiency
B. Valine transaminase deficiency
C. Valine-branched chain amino acids transaminase deficiency
D. Leucine-branched chain amino acids transaminase deficiency

**Correct Answer:** .

**Core Concept:**
The correct answer lies in understanding the roles and deficiencies of specific enzymes involved in the catabolism of branched chain amino acids (BCAAs), namely leucine, isoleucine, and valine. These amino acids are essential for human nutrition, and their catabolism involves several enzymes.

**Why the Correct Answer is Right:**
BCAAs are catabolized through a series of enzymatic reactions, with key enzymes being a-keto acid decarboxylases. The correct answer, D (Leucine-branched chain amino acids transaminase deficiency), pertains to a specific enzyme involved in the degradation of leucine, isoleucine, and valine. Leucine-branched chain amino acids transaminase (L-BCAT) deficiency leads to a block in the first step of BCAA catabolism, resulting in impaired degradation of these amino acids.

**Why Each Wrong Option is Incorrect:**
A (Alanylglutaminase deficiency) is incorrect because alanylglutaminase plays a role in the ureagenesis pathway, not BCAA catabolism.
B (Valine transaminase deficiency) is incorrect because the correct enzyme is L-BCAT (Leucine-branched chain amino acids transaminase), not valine transaminase.
C (Valine-branched chain amino acids transaminase deficiency) is incorrect because the correct enzyme is L-BCAT (Leucine-branched chain amino acids transaminase), not valine-branched chain amino acids transaminase.

**Clinical Pearl:**
A deficiency in L-BCAT results in elevated plasma levels of BCAAs, which can be detected through blood tests. This deficiency is a rare genetic disorder characterized by hyperammonemia, hyperalaninemia, and hyperglycinemia, as well as elevated BCAAs. These findings can lead to neurological symptoms, such as developmental delay, seizures, and encephalopathy. Identifying and managing this condition is crucial, as early intervention can prevent severe neurological impairment and other complications.